Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Epysqli® (eculizumab-aagh) – New biosimilar approval

July 22, 2024 - Samsung Bioepis announced the FDA approval of Epysqli (eculizumab-aagh), biosimilar to AstraZeneca’s Soliris® (eculizumab).

Download PDF

Rx navigation